VM-802

N/A

Report date: 2025/01/26 15:58:00

Base Information

Drug NameVM-802

Drug Alias Nameanti-CD antigen CAR T-cell therapy (ViroMed)VM-802

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCD antigen modulatorsT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHelixmith Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHelixmith Co Ltd

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A